Abstract

Clinical trials of novel therapies for acute spinal cord injury (SCI) are challenging because variability in spontaneous neurologic recovery can make discerning actual treatment effects difficult. Unbiased Recursive Partitioning regression with Conditional Inference Trees (URP-CTREE) is a novel approach developed through analyses of a large European SCI database (European Multicenter Study about Spinal Cord Injury). URP-CTREE uses early neurologic impairment to predict achieved motor recovery, with potential to optimize clinical trial design by optimizing patient stratification and decreasing sample sizes. We performed external validation to determine how well a previously reported URP-CTREE model stratified patients into distinct homogeneous subgroups and predicted subsequent neurologic recovery in an independent cohort. We included patients with acute cervical SCI level C4–C6 from a prospective registry at a quaternary care center from 2004–2018 (n = 101) and applied the URP-CTREE model and evaluated Upper Extremity Motor Score (UEMS) recovery, considered correctly predicted when final UEMS scores were within a pre-specified threshold of 9 points from median; sensitivity analyses evaluated the effect of timing of baseline neurological examination. We included 101 patients, whose mean times from injury baseline and follow-up examinations were 6.1 days (standard deviation [SD] 17) and 235.0 days (SD 71), respectively. Median UEMS recovery was 7 points (interquartile range 2–12). One of the predictor variables was not statistically significant in our sample; one group did not fit progressively improving UEMS scores, and three of five groups had medians that were not significantly different from adjacent groups. Overall accuracy was 75%, but varied from 82% among participants whose examinations occurred at <12 h, to 64% at 12–24 h, and 58% at >24 h. A previous URP-CTREE model had limited ability to stratify an independent into homogeneous subgroups. Overall accuracy was promising, but may be sensitive to timing of baseline neurological examinations. Further evaluation of external validity in incomplete injuries, influence of timing of baseline examinations, and investigation of additional stratification strategies is warranted.

Highlights

  • Clinical trials of novel therapies for acute traumatic spinal cord injuries (SCIs) are extremely challenging because variability in spontaneous neurologic recovery can make discerning actual treatment effects difficult.[1]

  • We performed an external validation study to determine how well a previously reported URP-CTREE model stratified patients into distinct homogeneous subgroups and predicted subsequent neurologic recovery when applied to an independent cohort of patients’ data from an ongoing prospective observational study of patients with acute traumatic cervical spinal cord injury (SCI)

  • We considered recovery to be correctly predicted when final upper extremity motor score (UEMS) scores were within a prespecified threshold of 9 points from the median in each group, because that threshold was recently used in the sample size calculation of a current definitive randomized controlled trial of a neuroprotective agent in patients with acute traumatic complete and incomplete cervical SCI.[16]

Read more

Summary

Introduction

Clinical trials of novel therapies for acute traumatic spinal cord injuries (SCIs) are extremely challenging because variability in spontaneous neurologic recovery can make discerning actual treatment effects difficult.[1]. Study about Spinal Cord Injury (EMSCI) database.[8,9,10,11] URPCTREE is a statistical technique that uses early neurologic impairment to predict how much motor recovery individual patients will achieve, and sequentially partitions initially heterogeneous groups into increasingly more homogenous groups.[12] Tanadini and colleagues[8] applied URP-CTREE to an EMSCI sample of 159 patients with complete acute traumatic cervical spinal cord injuries and evaluated its prediction accuracy for upper extremity motor score (UEMS) scores at 6 months post-injury Their results suggested that URP-CTREE might optimize future clinical trials by providing a data-driven approach to early patient stratification

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call